SELLAS LIFE SCIENCES GROUP, INC.

Profile

Company Names

SELLAS LIFE SCIENCES GROUP, INC.
GALENA BIOPHARMA, INC.

Addresses

7 TIMES SQUARE, SUITE 2503, NEW YORK, NY 10036

2000 CROW CANYON PLACE, SUITE 380, SAN RAMON, CA 94583

4640 SW MACADAM AVENUE, SUITE 270, PORTLAND, OR 97239

Phone Numbers

646-200-5278
855-855-4253
612-492-7789

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$60,622,836.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-03-15 
$18,371,336.00 
$18,371,336.00 
$0.00 
 
4
2020-07-31 
$9,151,500.00 
$9,151,500.00 
$0.00 
Equity 
3
2016-07-13 
$9,100,000.00 
$9,100,000.00 
$0.00 
 
2
2016-05-10 
$24,000,000.00 
$24,000,000.00 
$0.00 
Debt 
1
2014-01-12 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
J. 
AHN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ACCESS PHARMACEUTICALS INC   |  GALENA BIOPHARMA, INC.
WILLIAM 
L. 
ASHTON 
DIRECTOR
GALENA BIOPHARMA, INC.   |  MEDICUS PHARMA LTD.
JOHN 
T. 
BURNS 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.   |  SELLAS LIFE SCIENCES GROUP, INC.
RICHARD 
 
CHIN 
DIRECTOR
EVERYSCAPE INC   |  KINDRED BIOSCIENCES, INC.   |  BALANCE THERAPEUTICS, INC.   |  GALENA BIOPHARMA, INC.   |  VETMAB BIOSCIENCES, INC.   |  BIO USAWA INC.
RICHARD 
 
CHIN, M.D. 
DIRECTOR
GALENA BIOPHARMA, INC.   |  IMMUSOFT CORP   |  NACUITY PHARMACEUTICALS, INC.
RYAN 
 
DUNLAP 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.   |  MOLECULARMD CORP.   |  CYTODYN INC.
IRVING 
M. 
EINHORN 
DIRECTOR
GALENA BIOPHARMA, INC.
STEPHEN 
 
GALLIKER 
DIRECTOR
MITOMICS INC.   |  GALENA BIOPHARMA, INC.
STEPHEN 
S. 
GALLIKER 
DIRECTOR
MITOMICS INC.   |  GALENA BIOPHARMA, INC.
MARY 
ANN 
GRAY 
DIRECTOR
GALENA BIOPHARMA, INC.
MARY 
ANN 
GRAY, PH.D. 
DIRECTOR
GALENA BIOPHARMA, INC.
BRIAN 
 
HAMILTON, M.D., PH.D. 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.
SANFORD 
J. 
HILLSBERG 
DIRECTOR
GALENA BIOPHARMA, INC.   |  NACUITY PHARMACEUTICALS, INC.
KATHERINE 
BACH 
KALIN 
DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.
THOMAS 
J. 
KNAPP 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.
STEVEN 
A. 
KRIEGSMAN 
DIRECTOR
GALENA BIOPHARMA, INC.
BIJAN 
 
NEJADNIK 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.   |  EUREKA THERAPEUTICS, INC.
BIJAN 
 
NEJADNIK, M.D. 
EXECUTIVE OFFICER
GALENA BIOPHARMA, INC.
RUDOLPH 
 
NISI 
DIRECTOR
GALENA BIOPHARMA, INC.
RUDOLPH 
 
NISI, M.D. 
DIRECTOR
GALENA BIOPHARMA, INC.
ROBERT 
VAN 
NOSTRAND 
DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.
DAVID 
A. 
SCHEINBERG 
DIRECTOR
PROGENICS PHARMACEUTICALS INC   |  SELLAS LIFE SCIENCES GROUP, INC.
MARK 
W. 
SCHWARTZ 
EXECUTIVE OFFICER, DIRECTOR
BAYHILL THERAPEUTICS, INC.   |  GALENA BIOPHARMA, INC.
MARK 
W. 
SCHWARTZ, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
GALENA BIOPHARMA, INC.
ANGELOS 
M. 
STERGIOU 
EXECUTIVE OFFICER, DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.
ROBERT 
L. 
VAN NOSTRAND 
DIRECTOR
ACHILLION PHARMACEUTICALS INC   |  METABOLIX, INC.   |  ENUMERAL BIOMEDICAL HOLDINGS, INC.   |  YIELD10 BIOSCIENCE, INC.   |  SELLAS LIFE SCIENCES GROUP, INC.
JOHN 
 
VARIAN 
DIRECTOR
ARYX THERAPEUTICS, INC.   |  SELLAS LIFE SCIENCES GROUP, INC.
JANE 
 
WASMAN 
DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.   |  ATHERSYS, INC / NEW
BARBARA 
A. 
WOOD 
EXECUTIVE OFFICER
SELLAS LIFE SCIENCES GROUP, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-03-15 
2020-08-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2016-07-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2016-07-13 
2016-05-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-05-10 
2014-01-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-01-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361
NA
NONE
MAXIM GROUP LLC
120708
RAYMOND JAMES + ASSOCIATES, INC.
705
RAYMOND JAMES + ASSOCIATES, INC.
705
TRUMP SECURITIES, LLC
47107
ARMENTUM PARTNERS, LLC
NONE